Aspirina Case Instructive For Trademark Practitioners

Law360, New York (June 18, 2007, 12:00 AM EDT) -- In the case of In re Bayer AG, --F.3d--, 2007 WL 1502078 (Fed.Cir. May 24, 2007) (“Fed.Cir. Decision”), the Federal Circuit affirmed the Trademark Trial and Appeal Board’s holding that “Aspirina” is merely descriptive for analgesics.

The court’s opinion, as well as the TTAB’s underlying Order (2005 WL 3395183 (TTAB Dec. 1, 2005)) (“TTAB Order”), prove instructive to trademark practitioners on a variety of issues, as discussed below in Section II.

* Summary of Decision and Dissent *

Bayer AG (“Bayer”) applied to register Aspirina for...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.